NOT MEDICAL ADVICE.  For educational purposes only. Always consult a qualified healthcare provider.

Dengue Fever 2024 — What Is Happening?

2024 was the worst year for dengue in recorded history. Global cases exceeded 12 million by mid-2024, more than double the same period in 2023 (itself a record year). Brazil alone reported over 6 million cases in the first half of 2024 — more than any single country in any full year previously — with over 3,000 deaths. Argentina, Paraguay, and other Latin American countries also experienced unprecedented outbreaks. WHO described 2024 as a dengue "global emergency" driven by climate change, urban growth, and international travel extending both Aedes mosquito range and virus transmission.

Country/Region2024 Cases (approx.)Notable
Brazil6+ million (Jan–Jun 2024)All-time national record; WHO emergency response
Argentina450,000+Largest outbreak in Argentine history
Paraguay180,000+State of emergency declared
Peru220,000+Highest recorded in 30 years of surveillance
Bangladesh300,000+ (second consecutive record)Predominantly DENV-2 serotype
IndiaSignificant increaseMulti-serotype circulation including DENV-3
Southeast Asia overallSignificant increasePhilippines, Vietnam, Indonesia all reporting high counts

Multiple overlapping factors drove the 2024 surge:

  • El Niño weather pattern (2023–2024): Warmer temperatures and altered rainfall patterns created ideal Aedes mosquito breeding conditions across Latin America and Asia
  • Expanding geographic range: Climate change enabling year-round Aedes activity in previously seasonal zones
  • Serotype shift: Increased circulation of DENV-3 and DENV-2 in populations previously dominated by DENV-1, creating more people encountering a second serotype (and facing higher severe dengue risk)
  • Post-COVID immunity gap: Lockdowns from 2020–2022 reduced dengue exposure, leaving a larger-than-normal population of people without prior dengue immunity encountering the virus in 2023–2024
  • Urban growth: Expanding urban populations in Aedes-endemic regions with inadequate water management and waste disposal creating more mosquito breeding sites

The 2024 outbreak accelerated vaccine deployment:

  • Qdenga (Takeda): Approved in Brazil, multiple EU countries, and expanding markets; Brazil began a national school vaccination programme in February 2024
  • Dengvaxia: Still used in Philippines for confirmed seropositive children 9–16 years old
  • WHO recommendation: Either vaccine for high-burden settings with appropriate seroprevalence data

Vaccine supply was insufficient to meet demand at the scale of the 2024 outbreak; manufacturing capacity expansion is a priority for both manufacturers.

Is dengue getting worse each year?
The trend is clearly worsening. WHO reports a nearly 10-fold increase in dengue cases over the past 20 years, from ~500,000 cases in 2000 to 5 million+ in 2019 and 12+ million in 2024. Climate projections suggest continued geographic expansion and increased outbreak intensity through 2050, with an additional 1–2 billion people at risk if temperatures rise 2°C above pre-industrial levels.
What is being done about the dengue outbreak globally?
WHO's Global Dengue Programme coordinates surveillance, outbreak response, and vaccine research. At national level: Brazil's national dengue response in 2024 included emergency hospital capacity expansion, military deployment for vector control, and accelerated Qdenga vaccination. Ongoing efforts include Wolbachia-infected mosquito release programmes (which reduce dengue transmission by 77% in trials) expanding across multiple countries.
Should travelers avoid dengue-endemic countries in 2024–2025?
Travel advisories are not in place for dengue (unlike some other infectious diseases). Travelers should take mosquito bite prevention seriously — DEET repellent, long clothing, accommodation with air conditioning or screens. High-risk travelers (pregnant women, those with prior dengue who are planning to travel to areas with different serotypes) may want to discuss risks with a travel medicine specialist. No blanket travel restrictions are recommended.